Market Closed -
Nasdaq
01:30:00 01/06/2024 am IST
|
5-day change
|
1st Jan Change
|
5.57
USD
|
-.--%
|
|
-2.28%
|
-28.86%
|
Fiscal Period: December |
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
3,562
|
1,857
|
2,964
|
2,129
|
-
|
-
|
Enterprise Value (EV)
1 |
3,585
|
1,974
|
3,166
|
2,266
|
2,253
|
2,161
|
P/E ratio
|
-9.07
x
|
-8.1
x
|
-15.4
x
|
-23.1
x
|
-25.8
x
|
-40.4
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
5.34
x
|
2.16
x
|
2.81
x
|
1.75
x
|
1.55
x
|
1.37
x
|
EV / Revenue
|
5.37
x
|
2.3
x
|
3
x
|
1.86
x
|
1.64
x
|
1.39
x
|
EV / EBITDA
|
72.9
x
|
37.5
x
|
53.6
x
|
25.3
x
|
18.5
x
|
13.6
x
|
EV / FCF
|
-42.1
x
|
-74.6
x
|
-55.2
x
|
214
x
|
57.8
x
|
37.9
x
|
FCF Yield
|
-2.37%
|
-1.34%
|
-1.81%
|
0.47%
|
1.73%
|
2.64%
|
Price to Book
|
2.31
x
|
1.22
x
|
2.08
x
|
1.53
x
|
1.54
x
|
1.54
x
|
Nbr of stocks (in thousands)
|
3,74,149
|
3,75,986
|
3,78,607
|
3,82,288
|
-
|
-
|
Reference price
2 |
9.520
|
4.940
|
7.830
|
5.570
|
5.570
|
5.570
|
Announcement Date
|
10/03/22
|
08/03/23
|
28/02/24
|
-
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
377.2
|
667.5
|
859.5
|
1,056
|
1,218
|
1,377
|
1,557
|
EBITDA
1 |
-
|
49.15
|
52.67
|
59.04
|
89.65
|
122
|
159.4
|
EBIT
1 |
-
|
-286.4
|
-210.2
|
-189.1
|
-79.1
|
-66.9
|
-36.9
|
Operating Margin
|
-
|
-42.9%
|
-24.45%
|
-17.92%
|
-6.5%
|
-4.86%
|
-2.37%
|
Earnings before Tax (EBT)
1 |
-
|
-333.1
|
-232.7
|
-206.6
|
-102.3
|
-85.71
|
-61.04
|
Net income
1 |
-311.3
|
-343.9
|
-215.6
|
-186.3
|
-89.93
|
-76.33
|
-48.03
|
Net margin
|
-82.53%
|
-51.53%
|
-25.08%
|
-17.64%
|
-7.39%
|
-5.54%
|
-3.09%
|
EPS
2 |
-
|
-1.050
|
-0.6100
|
-0.5100
|
-0.2407
|
-0.2157
|
-0.1379
|
Free Cash Flow
1 |
-
|
-85.07
|
-26.47
|
-57.4
|
10.57
|
39
|
57
|
FCF margin
|
-
|
-12.74%
|
-3.08%
|
-5.44%
|
0.87%
|
2.83%
|
3.66%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
11.8%
|
31.95%
|
35.76%
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
12/04/21
|
10/03/22
|
08/03/23
|
28/02/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
190.1
|
203.1
|
209.5
|
217.6
|
229.4
|
252.6
|
259.6
|
262.9
|
280.6
|
300.4
|
306
|
301.7
|
312.4
|
330
|
336.4
|
EBITDA
1 |
11.4
|
12.48
|
14.63
|
15.38
|
10.18
|
10.1
|
14.06
|
14.58
|
20.29
|
27.65
|
22.38
|
21.65
|
23.11
|
26.58
|
29.49
|
EBIT
1 |
-113.8
|
-64.85
|
-60.47
|
-38.84
|
-46.01
|
-34.09
|
-48.41
|
-74.36
|
-32.27
|
-16.77
|
-27.4
|
-26.4
|
-23.9
|
-
|
-
|
Operating Margin
|
-59.84%
|
-31.93%
|
-28.86%
|
-17.85%
|
-20.06%
|
-13.5%
|
-18.65%
|
-28.28%
|
-11.5%
|
-5.58%
|
-8.95%
|
-8.75%
|
-7.65%
|
-
|
-
|
Earnings before Tax (EBT)
1 |
-118.6
|
-69
|
-67.8
|
-42.21
|
-53.72
|
-38.28
|
-52.02
|
-77.97
|
-38.32
|
-20.73
|
-30
|
-30
|
-28
|
-
|
-
|
Net income
1 |
-144.8
|
-62.33
|
-68.73
|
-37.85
|
-46.66
|
-34.24
|
-45.48
|
-61.58
|
-44.96
|
-21.1
|
-29.15
|
-28.2
|
-25.85
|
-
|
-
|
Net margin
|
-76.16%
|
-30.69%
|
-32.8%
|
-17.4%
|
-20.34%
|
-13.56%
|
-17.52%
|
-23.42%
|
-16.02%
|
-7.02%
|
-9.53%
|
-9.35%
|
-8.28%
|
-
|
-
|
EPS
2 |
-0.3200
|
-0.1800
|
-0.1900
|
-0.1100
|
-0.1300
|
-0.0900
|
-0.1300
|
-0.1700
|
-0.1200
|
-0.0600
|
-0.0614
|
-0.0656
|
-0.0640
|
-0.0550
|
-0.0468
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
10/03/22
|
09/05/22
|
09/08/22
|
08/11/22
|
08/03/23
|
10/05/23
|
09/08/23
|
08/11/23
|
28/02/24
|
09/05/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
23.5
|
116
|
201
|
137
|
124
|
31.3
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
0.4783
x
|
2.211
x
|
3.412
x
|
1.526
x
|
1.014
x
|
0.1963
x
|
Free Cash Flow
1 |
-
|
-85.1
|
-26.5
|
-57.4
|
10.6
|
39
|
57
|
ROE (net income / shareholders' equity)
|
-
|
-27.1%
|
-14.1%
|
-12.6%
|
-6.48%
|
-5.03%
|
-3.32%
|
ROA (Net income/ Total Assets)
|
-
|
-19.7%
|
-10.5%
|
-8.7%
|
-5.07%
|
-3.9%
|
-3.18%
|
Assets
1 |
-
|
1,748
|
2,050
|
2,142
|
1,773
|
1,960
|
1,511
|
Book Value Per Share
2 |
-
|
4.130
|
4.040
|
3.770
|
3.650
|
3.620
|
3.630
|
Cash Flow per Share
2 |
-
|
0.0300
|
0.1500
|
-0.0500
|
0.1100
|
0.2400
|
-
|
Capex
1 |
-
|
94.5
|
79.3
|
40.5
|
32.6
|
57.3
|
68.7
|
Capex / Sales
|
-
|
14.16%
|
9.22%
|
3.84%
|
2.67%
|
4.16%
|
4.41%
|
Announcement Date
|
12/04/21
|
10/03/22
|
08/03/23
|
28/02/24
|
-
|
-
|
-
|
Last Close Price
5.57
USD Average target price
8.786
USD Spread / Average Target +57.73% Consensus |
1st Jan change
|
Capi.
|
---|
| -28.86% | 2.13B | | +25.52% | 88.99B | | -24.52% | 74.82B | | +0.49% | 25.03B | | +4.31% | 17.88B | | -14.25% | 16.43B | | +2.97% | 15.77B | | +79.20% | 13.21B | | +70.11% | 13.08B | | +40.44% | 12.9B |
Other Healthcare Facilities & Services
|